CareDx(US:CDNA) ZACKS·2025-11-05 00:16Core Insights - CareDx reported quarterly earnings of $0.28 per share, exceeding the Zacks Consensus Estimate of $0.13 per share, and showing an increase from $0.14 per share a year ago, resulting in an earnings surprise of +115.38% [1] - The company achieved revenues of $100.06 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 5.07% and up from $82.88 million year-over-year [2] Earnings Performance - Over the last four quarters, CareDx has surpassed consensus EPS estimates three times, indicating a positive trend in earnings performance [2] - The company had a previous earnings expectation of $0.12 per share but reported $0.10, resulting in a surprise of -16.67% [1] Stock Performance - CareDx shares have declined approximately 31% since the beginning of the year, contrasting with the S&P 500's gain of 16.5% [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it is expected to perform in line with the market in the near future [6] Future Outlook - The current consensus EPS estimate for the upcoming quarter is $0.19 on revenues of $101.74 million, and for the current fiscal year, it is $0.51 on revenues of $368.34 million [7] - The outlook for the Medical Services industry, where CareDx operates, is currently in the bottom 43% of Zacks industries, which may impact the stock's performance [8]